Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40805-79-6 | MDL No. : | MFCD00235052 |
Formula : | C5H3N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XVIAPHVAGFEFFN-UHFFFAOYSA-N |
M.W : | 105.10 | Pubchem ID : | 10197646 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 26.75 |
TPSA : | 49.57 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.3 cm/s |
Log Po/w (iLOGP) : | 0.96 |
Log Po/w (XLOGP3) : | -0.5 |
Log Po/w (WLOGP) : | 0.35 |
Log Po/w (MLOGP) : | -1.08 |
Log Po/w (SILICOS-IT) : | 0.92 |
Consensus Log Po/w : | 0.13 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.73 |
Solubility : | 19.5 mg/ml ; 0.186 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.07 |
Solubility : | 88.8 mg/ml ; 0.845 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.67 |
Solubility : | 2.26 mg/ml ; 0.0215 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.18 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: With triethylamine; trifluoroacetic anhydride In dichloromethane at 0 - 20℃; Stage #2: With sodium hydroxide In dichloromethane; water |
Pyrimidine-5-carbonitrile (SO3-067): To a suspension of pyrimidine-5-carboxamide (SOS- OSS) (262 mg, 2.12 mmol) and triethyl amine (481 mg, 4.24 mmol) in anhydrous dichoromethane (15 ml) was slowly added a solutionf of trifuoroacetic anhydride (0.36 ml in 4 ml dichloromethane) at 0°C. The reaction mixture was stirred at 0°C to RT for 2 h. and quenched with water (2ml) and washed with NaOH (1 N, 5 ml) and brine (2 x 5 ml). Organic solvent was dried (MgS04) and evaporated at less than 30°C to provide SO3-067 as a pale yellow solid. (1 74 mg, 78percent). 1 H NM R (400 M Hz, DMSO) δ 9.44 (s, 1 H), 9.31 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With 1-Butylimidazole In toluene at 160℃; for 16 h; | In an autoclave, 1 equiv. of aryl halide or heteroaryl halide, 2 equiv. of 1-alkylimidazole, 0.1 equiv. of CuI, 0.2 equiv. of dried K4[Fe(CN)6] (potassium hexacyanoferrate(II)), tetradecane as an internal standard for the GC analysis and a suitable amount of toluene were combined under argon and heated to 160 C. (The K4[Fe(CN)6] was dried by heating powdered K4[Fe(CN)6]x3H2O in a vacuum of 1 mbar to 80 C. for at least 24 hours.) After 16 hours, the reaction mixture was cooled to room temperature. Conversion and yield were determinable by means of gas chromatography. An isolation of the product took place according to the customary workup (distillation, crystallization or chromatography). |
82% | With 1-methyl-1H-imidazole In toluene at 160℃; for 16 h; | In an autoclave, 1 equiv. of aryl halide or heteroaryl halide, 2 equiv. of 1-alkylimidazole, 0.1 equiv. of CuI, 0.2 equiv. of dried K4[Fe(CN)6] (potassium hexacyanoferrate(II)), tetradecane as an internal standard for the GC analysis and a suitable amount of toluene were combined under argon and heated to 160 C. (The K4[Fe(CN)6] was dried by heating powdered K4[Fe(CN)6]x3H2O in a vacuum of 1 mbar to 80 C. for at least 24 hours.) After 16 hours, the reaction mixture was cooled to room temperature. Conversion and yield were determinable by means of gas chromatography. An isolation of the product took place according to the customary workup (distillation, crystallization or chromatography). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With dmap; 1,1'-bis-(diphenylphosphino)ferrocene; nickel(II) chloride hexahydrate; zinc In acetonitrile at 80℃; for 4 h; Inert atmosphere; Sealed tube | General procedure: Under argon protection, NiCl2·6H2O (0.05mmo 1,11.9mg), dppf (0.06mmol, 33.3mg), Ζn (0·2mmol, 13.0mg), DMAP (1.0mmol, 122.2mg), Ζn(CN)2 (0.8mmol) , 93.9mg),p-Chloroanisole (1.0 mmol, 140.6 mg) and acetonitrile (5.0 mL) were sequentially added in a 25.0 mL sealed tube, then directly put it into the oil bath at 60 °C, and heating was stopped after 6h, and cooled to room temperature, the reaction solution was directly filtered through a short silica gel column, washed with dichloromethane, concentrated and purified by silica gel column chromatography( given that the product is most easily pulled out, in order to avoid loss of sample mix, unless otherwise noted, both are wet method). Eluent: petroleum ether / ethyl acetate = 20:1, the product was 117.2 mg as a white solid, yield 88percent, and 1H NMR purity was greater than 98percent. |
[ 1753-48-6 ]
2-Aminopyrimidine-5-carbonitrile
Similarity: 0.86
[ 16357-69-0 ]
4-Aminopyrimidine-5-carbonitrile
Similarity: 0.86
[ 1753-50-0 ]
2-Chloropyrimidine-5-carbonitrile
Similarity: 0.78
[ 4774-34-9 ]
4-Hydroxypyrimidine-5-carbonitrile
Similarity: 0.73
[ 17321-97-0 ]
2-Amino-4-methylpyrimidine-5-carbonitrile
Similarity: 0.72
[ 1753-48-6 ]
2-Aminopyrimidine-5-carbonitrile
Similarity: 0.86
[ 16357-69-0 ]
4-Aminopyrimidine-5-carbonitrile
Similarity: 0.86
[ 1753-50-0 ]
2-Chloropyrimidine-5-carbonitrile
Similarity: 0.78
[ 4774-34-9 ]
4-Hydroxypyrimidine-5-carbonitrile
Similarity: 0.73